Molina Healthcare (NYSE:MOH) had its price objective trimmed by Morgan Stanley from $94.00 to $91.00 in a report issued on Wednesday morning. The brokerage currently has an overweight rating on the stock.
Several other brokerages have also commented on MOH. Jefferies Group upped their price target on Molina Healthcare from $64.00 to $74.00 and gave the company a hold rating in a research note on Friday, November 3rd. Goldman Sachs Group started coverage on Molina Healthcare in a research note on Wednesday, January 3rd. They issued a neutral rating and a $83.00 price target on the stock. Wolfe Research raised Molina Healthcare from a market perform rating to an outperform rating in a research note on Monday, October 23rd. ValuEngine lowered Molina Healthcare from a buy rating to a hold rating in a research note on Friday, December 1st. Finally, Zacks Investment Research raised Molina Healthcare from a sell rating to a hold rating in a research note on Monday, November 6th. Three investment analysts have rated the stock with a sell rating, eleven have issued a hold rating and four have assigned a buy rating to the stock. The stock currently has a consensus rating of Hold and an average target price of $73.73.
Molina Healthcare (MOH) opened at $72.12 on Wednesday. Molina Healthcare has a 12 month low of $42.56 and a 12 month high of $93.98. The company has a market capitalization of $4,333.51, a price-to-earnings ratio of -8.00, a PEG ratio of 1.32 and a beta of 1.10. The company has a quick ratio of 1.29, a current ratio of 1.35 and a debt-to-equity ratio of 1.13.
A number of institutional investors and hedge funds have recently bought and sold shares of MOH. Iridian Asset Management LLC CT acquired a new stake in Molina Healthcare in the 4th quarter valued at about $128,179,000. Southpoint Capital Advisors LP acquired a new stake in Molina Healthcare in the 4th quarter valued at about $60,577,000. Renaissance Technologies LLC raised its position in Molina Healthcare by 53.5% in the 4th quarter. Renaissance Technologies LLC now owns 2,156,150 shares of the company’s stock valued at $165,334,000 after purchasing an additional 751,800 shares in the last quarter. Jana Partners LLC raised its position in Molina Healthcare by 52.5% in the 3rd quarter. Jana Partners LLC now owns 2,125,351 shares of the company’s stock valued at $146,139,000 after purchasing an additional 731,992 shares in the last quarter. Finally, Tavio Capital LLC raised its position in Molina Healthcare by 418.0% in the 3rd quarter. Tavio Capital LLC now owns 537,192 shares of the company’s stock valued at $36,937,000 after purchasing an additional 433,485 shares in the last quarter. 96.22% of the stock is currently owned by hedge funds and other institutional investors.
About Molina Healthcare
Molina Healthcare, Inc offers Medicaid-related solutions for low-income families and individuals, and assists government agencies in their administration of the Medicaid program. The Company operates through three segments: Health Plans, Molina Medicaid Solutions and Other, which includes its Pathways Health and Community Support LLC (Pathways) business.
Receive News & Ratings for Molina Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Molina Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.